Publications

1. Everolimus (Votubia) for the indication 'treatment of patients aged 3 years and older with subependymal giant cell astrocytoma associated with tuberous sclerosis complex

   The use of everolimus for the treatment of patients aged 3 years and older with subependymal giant cell astrocytomas (SEGA) ...

   Report | 23-01-2012

2. Background report assessing whether occipital neurostimulation for chronic cluster headache complies with established medical science and medical practice

   Occipital neurostimulation in cases of refractory chronic cluster headaches does not comply with the ‘established medical science ...

   Report | 22-11-2011

3. Transcatheter aortic valve replacement

   In the opinion of CVZ, TAVI (transcatheter aortic valve implantation) is care that complies with established medical science and ...

   Report | 26-10-2011

4. Infliximab (Remicade) for the indication 'plaque psoriasis’

   Infliximab and adalimumab, etanercept and ustekinumab are of equal therapeutic value in the treatment of adults suffering from ...

   Report | 24-10-2011

5. Infliximab (Remicade) for the indication 'colitis ulcerosa’

   For the treatment of moderate to severe cases of colitis ulcerosa, in comparison with ciclosporin, infliximab has a therapeutic ...

   Report | 24-10-2011

6. Nursing in AWBZ institutions

   The questions focus on nursing care that is necessary in connection with that medical specialist care. CVZ acknowledges that the ...

   Report | 29-09-2011

7. Sunitinib malate (Sutent) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours

   For the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression ...

   Report | 26-09-2011

8. Preferential policy towards biological drugs

   CVZ regards biological drugs as therapeutically interchangeable if they are designated as "similar" after being registered by the ...

   Report | 26-09-2011

9. Eslicarbazepine (Zebinix) for the ‘adjunctive treatment of partial onset seizures with or without secondary generalisation in adults with epilepsy’

   The therapeutic value of eslicarbazepine as an adjunctive treatment for partial epilepsy is comparable with that of ...

   Report | 26-09-2011

10. Apixaban (Eliquis) for the prevention of venous thromboembolic events

    For the prevention of venous thromboembolic events in adults after a hip or knee replacement operation apixaban has an added ...

    Report | 26-09-2011